Metabolic Consequences of Treatment With AKT Inhibitor Perifosine in Breast Cancer Cells

NMR in Biomedicine - United States
doi 10.1002/nbm.1764
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

PARP Inhibitor Treatment in Ovarian and Breast Cancer

Current Problems in Cancer
Cancer ResearchOncology
2011English

AKT Inhibitor Suppresses Hyperthermia-Induced Ndrg2 Phosphorylation in Gastric Cancer Cells

Brazilian Journal of Medical and Biological Research
ImmunologyCell BiologyPharmacologyBiochemistryBiophysicsNeuroscienceMedicineToxicologyPhysiologyPharmaceutics
2013English

IKKβ Inhibitor in Combination With Bortezomib Induces Cytotoxicity in Breast Cancer Cells

International Journal of Oncology
Cancer ResearchOncology
2014English

Akt Rescue in Cardiomyocytes but Not Breast Cancer Cells After Doxorubicin and Anti-erbB2 Treatment

2005English

Metabolic Consequences of HIF Silencing in a Triple Negative Human Breast Cancer Xenograft

Oncotarget
Oncology
2018English

The ATM Inhibitor KU-55933 Suppresses Cell Proliferation and Induces Apoptosis by Blocking Akt in Cancer Cells With Overactivated Akt

Molecular Cancer Therapeutics
Cancer ResearchOncology
2010English

Inhibition of mTOR Activity Restores Tamoxifen Response in Breast Cancer Cells With Aberrant Akt Activity

Clinical Cancer Research
Cancer ResearchOncology
2004English

Cosmetic Consequences of Breast‐Conserving Treatment for Breast Cancer: Something Worth Talking About

Oncologist
Cancer ResearchMedicineOncology
2018English

BikDD Eliminates Breast Cancer Initiating Cells and Synergizes With Lapatinib for Breast Cancer Treatment

Cancer Cell
Cancer ResearchOncologyCell Biology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy